Correlation Between Rani Therapeutics and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rani Therapeutics and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rani Therapeutics and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rani Therapeutics Holdings and Stoke Therapeutics, you can compare the effects of market volatilities on Rani Therapeutics and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rani Therapeutics with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rani Therapeutics and Stoke Therapeutics.
Diversification Opportunities for Rani Therapeutics and Stoke Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Rani and Stoke is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Rani Therapeutics Holdings and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Rani Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rani Therapeutics Holdings are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Rani Therapeutics i.e., Rani Therapeutics and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Rani Therapeutics and Stoke Therapeutics
Given the investment horizon of 90 days Rani Therapeutics Holdings is expected to under-perform the Stoke Therapeutics. In addition to that, Rani Therapeutics is 1.04 times more volatile than Stoke Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Stoke Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 1,269 in Stoke Therapeutics on August 31, 2024 and sell it today you would lose (58.00) from holding Stoke Therapeutics or give up 4.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Rani Therapeutics Holdings vs. Stoke Therapeutics
Performance |
Timeline |
Rani Therapeutics |
Stoke Therapeutics |
Rani Therapeutics and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rani Therapeutics and Stoke Therapeutics
The main advantage of trading using opposite Rani Therapeutics and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rani Therapeutics position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |